Jeevan Scientific Technology is currently trading at Rs. 39.80, up by 1.85 points or 4.87% from its previous closing of Rs. 37.95 on the BSE.
The scrip opened at Rs. 39.80 and has touched a high and low of Rs. 39.80 and Rs. 39.80 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 56.00 on 13-Dec-2016 and a 52 week low of Rs. 24.00 on 06-Sep-2016.
Last one week high and low of the scrip stood at Rs. 39.80 and Rs. 35.00 respectively. The current market cap of the company is Rs. 32.30 crore.
The promoters holding in the company stood at 30.41%, while Public held 69.59% stake in the company.
Jeevan Scientific Technology (JST) has completed the audit conducted by USFDA at its corporate and clinical pharmacology centre facilities. No 483 observations were issued to the company.
The US Food and Drug Administration (USFDA) had conducted an un-announced audit at the company’s corporate and clinical pharmacology centre facilities. The purpose of this audit was to review the BA/BE studies. The auditor started the review on Jun 05, 2017 and completed on Jun 08, 2017.
Jeevan Scientific Technology provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.